Clinical Trials
8 trialsNCT01333033 2023-04-13
PET Scan Imaging in Assessing Response in Patients With Esophageal Cancer Receiving Combination Chemotherapy
Alliance for Clinical Trials in Oncology
Phase 2 Completed
NCT02139488 2019-06-27
Organ Motion and Early Tumor Response Measurement
The Netherlands Cancer Institute
Completed
NCT01561014 2018-07-02
Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Wake Forest University Health Sciences
Phase 1 Completed
NCT00004867 2017-01-24
Positron Emission Tomography in Determining Stage of Esophageal Cancer
Alliance for Clinical Trials in Oncology
Phase NA Completed
NCT00833625 2016-10-28
FDG-PET-CT and Biomarkers in Esophageal Cancer
M.D. Anderson Cancer Center
Phase NA Completed
NCT01129206 2016-06-01
Pralatrexate and Docetaxel in Treating Patients With Stage IV Esophageal or Gastroesophageal Cancer Who Have Failed Platinum-Based Therapy
Ohio State University Comprehensive Cancer Center
Phase 2 Completed
NCT00867477 2014-08-28
PMRR-NO: Pulmonary Metabolic Radiation Response Versus Exhaled Nitric Oxide
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00002930 2013-01-18
PET Scan in Patients With Lung and Esophageal Cancers That May Be Removed by Surgery
Memorial Sloan Kettering Cancer Center
Phase 2/3 Completed